Aldeyra Therapeutics, Inc. (ALDX:NASDAQ) soared at $2.54, a gain of 48.5%. On Wed, Nov 01, 2023, ALDX:NASDAQ hit a New 2-Week High of $2.54. The stock appeared on our News Catalysts scanner on Wed, Nov 01, 2023 at 09:00 AM in the 'AGREEMENT' category. From Wed, Oct 18, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Jun 15, 2023 at $11.97 with a volume of 2M+.
About Aldeyra Therapeutics, Inc. (ALDX:NASDAQ)
Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.
Top 10 Gainers:
- Cellectis S.A. (CLLS:NASDAQ), 173.86%
- Patriot Transportation Holding, Inc. (PATI:NASDAQ), 103.13%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 48.54%
- Sientra, Inc. (SIEN:NASDAQ), 32.95%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 31.45%
- PMV Pharmaceuticals Inc. (PMVP:NASDAQ), 31.13%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 30.92%
- Local Bounti Corporation (LOCL:NYSE), 30.12%
- Precision BioSciences, Inc. (DTIL:NASDAQ), 29.63%
- Silence Therapeutics Plc (SLN:NASDAQ), 29.25%